Skip to main content
SpringerLink
Log in

The Role of Prostate-Specific Antigen in the Management of Prostate Cancer

  • Chapter
Carcinoma of the Prostate

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

The prostate is the largest male excretory sex gland, secreting four major proteins primarily to the seminal ejaculate. These four proteins are: prostatic acid phosphatase (PAP), prostate-specific antigen (PSA), prostate-specific protein (PSP-94), and human kallikrein 2 (hK2) (Table 14.1). At the present time the biochemical and pathologic mechanisms for the entry of these proteins into the systemic circulation are not well understood.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abdel-Nabi H, Wright GL, Gulfo JV et al. (1992) Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer. Semin Urol X (1): 4554

    Google Scholar 

  • Babaian J, Myiashita H, Evans RB (1992) The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age. J Urol 147: 837–840

    PubMed  CAS  Google Scholar 

  • Benson MC (1994) Editorial: prostate specific antigen. J Urol 152: 2046–2048

    PubMed  CAS  Google Scholar 

  • Benoit RM, Naslund MJ (1994) An economic rationale for prostate cancer screening. Urology 44: 795–803

    Article  PubMed  CAS  Google Scholar 

  • Bluestein DL, Bostwick DG, Bergstrahl EJ et al. (1994) Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151: 1315–1320

    PubMed  CAS  Google Scholar 

  • Bostwick DG (1994) Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer. Am J Clin Pathol 102 (Suppl 1): S31 - S37

    PubMed  CAS  Google Scholar 

  • Brawer MK, Aramburu EAG, Chen GL et al. (1993a) The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol 150: 369–373

    CAS  Google Scholar 

  • Brawer MK, Beatie J, Wener MH et al. (1993b) Screening for prostatic carcinoma with prostatic specific antigen: results of the second year. J Urol 150: 106–109

    CAS  Google Scholar 

  • Bretton PR, Evans WP, Borden JD et al. (1994) The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma. Cancer 74: 2991–2995

    Article  PubMed  CAS  Google Scholar 

  • Breul J, Pickl U, Hartung R (1993) Prostate specific antigen in urine and saliva. J Urol 149: 302A

    Google Scholar 

  • Carter HB, Pearson JD, Metter EJ et al. (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without disease. JAMA 267: 2215–2220

    Article  PubMed  CAS  Google Scholar 

  • Carter HB, Chan DW, Pearson JD et al. (1995) Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity. Urology 45: 591–596

    Article  PubMed  CAS  Google Scholar 

  • Catalona WJ, Smith DS, Ratliff TL et al. (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156–1161

    Article  PubMed  CAS  Google Scholar 

  • Catalona WJ, Richie JP, Ahmann FR et al. (1994a) Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol 151: 1283–1290

    CAS  Google Scholar 

  • Catalona WJ, Richie JP, deKernion JB (1994b) Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol 152: 2031–2036

    CAS  Google Scholar 

  • Catalona WJ, Smith DS, Wolfert RL et al. (1995) Increasing specificity of PSA screening through measurement of percent free PSA in serum. J Urol 153: 312A

    Google Scholar 

  • Christensson A, Björk T, Nilsson O et al. (1993) Serum prostate specific antigen complexed to al-antichymotrypsin as an indicator of prostate cancer. J Urol 150: 100–105

    PubMed  CAS  Google Scholar 

  • Clements J, Mukhtar A (1994) Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 78: 1536–1539

    Article  PubMed  CAS  Google Scholar 

  • Coffey DS (1992) The molecular biology endocrinology and physiology of prostate and seminal vessels. In: Walsh PC, Retik AB, Stamey TA, Vaughan D (eds) Campbell’s urology. Saunders, Philadelphia, pp 221–266

    Google Scholar 

  • Cooner WH (1993) Definition of the ideal tumor marker. Urol Clin North Am 20: 575–579

    PubMed  CAS  Google Scholar 

  • Crawford ED, DeAntoni EP (1993) PSA as a screening test for prostate cancer. Urol Clin North Am 20: 637–646

    PubMed  CAS  Google Scholar 

  • Crawford ED, DeAntoni EP, Stone NN et al. (1995) Prostate cancer awareness week demonstrates continued value to early detection strategies. J Urol 153: 312A

    Google Scholar 

  • Danella J, Steckel J, Dorey F et al. (1993) Detectable prostate specific antigen levels following radical prostatectomy. J Urol 149: 447A

    Google Scholar 

  • Dawson NA, McLeod DG (1995) Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome. J Urol 153: 1946–1947

    Article  PubMed  CAS  Google Scholar 

  • Dietrick D, McNeal JE, Stamey TA (1995) Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volume. Urology 45: 987–992

    Article  PubMed  CAS  Google Scholar 

  • Djavan B, Keffer JH, Molberg K (1995) False-positive serum prostate-specific antigen values in a patient with non-Hodgkin lymphoma of the kidney. Urology 45: 875–878

    Article  PubMed  CAS  Google Scholar 

  • Dodson MK, Cliby WA, Keeney GL et al. (1994) Case report: Skene’s gland adenocarcinoma with increased serum level of prostate-specific antigen. Gynecol Oncol 55: 304–307

    Article  PubMed  CAS  Google Scholar 

  • Elgamal AA, Van de Voorde W, Van Poppel H et al. (1994a) Immunohistochemical localization of prostate-specific markers within the accessory male sex glands of Cowper, Littre and Morgagni. Urology 44: 84–90

    Article  Google Scholar 

  • Elgamal AA, Van de Voorde W, Van Poppel H et al. (1994b) Prostatic duct adenocarcinoma with endometrial features after TURP. Urology 43: 737–742

    Article  PubMed  CAS  Google Scholar 

  • Elgamal AA, Billen J, Van de Voorde W et al. (1995a) Verification and significance of PSA production by the periurethral glands. Proceedings of “Androgenic Hormones, Prostate Cancer and Benign Prostatic Hyperplasia”, International Conference, New Orleans, March 13–15

    Google Scholar 

  • Elgamal AA, Billen J, Van de Voorde W et al. (1995b) Extraprostatic sources of PSA, does it infer the subjective biochemical recurrence after radical prostatectomy? J Urol 153: 518A

    Google Scholar 

  • Elgamal AA, Van de Voorde WM, Van Poppel HP et al. (1995c) Selective zonal distribution of tumor volume versus grade in Tlc prostate cancer. J Urol 153: 484A

    Google Scholar 

  • Elgamal AA, Cornillie F, Van Poppel H et al. (1995d) Interpretation of free/total (F/T) PSA determinations in routine clinical practice (abstract). 23rd Meeting of the International Society for Oncodevelopmental Biology and Medicine (ISOBM), Montreal, Canada. September 10–13

    Google Scholar 

  • Ellis WJ, Chetner MP, Preston SD (1994) Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Urol 152: 1520–1525

    PubMed  CAS  Google Scholar 

  • Epstein JI (1993) PSA and PAP as immunohistochemical markers in prostate cancer. Urol Clin North Am 20: 757–770

    PubMed  CAS  Google Scholar 

  • Epstein JI, Walsh PC, Carmichael M et al. (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tic) prostate cancer. JAMA 271: 368

    Article  PubMed  CAS  Google Scholar 

  • Fichtner J, Graves H, Shortlife L et al. (1994) Prostate specific antigen releases a kinin-like substance that stimulates smooth muscle contraction. J Urol 151: 313A

    Google Scholar 

  • Frazier HA, Humphrey PA, Burchette JL et al. (1992) Immunoreactive prostatic specific antigen in male periurethral glands. J Urol 147: 246–248

    PubMed  CAS  Google Scholar 

  • Frazier HA, Robertson JE, Humphrey PA et al. (1993) Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy? J Urol 149: 516–518

    PubMed  CAS  Google Scholar 

  • Gann PH, Hennekens CH, Stampfer MJ (1995) A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 273: 289–294

    Article  PubMed  CAS  Google Scholar 

  • Goldrath DE, Messing EM (1989) Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy. J Urol 142: 1082–1084

    PubMed  CAS  Google Scholar 

  • Graves HCB (1993) Standardization of immunoassays for prostate-specific antigen. Cancer 72: 3141–3144

    Article  PubMed  CAS  Google Scholar 

  • Grob BM, Schellhammer PF, Brassil DN et al. (1994) Changes in immunohistochemical staining of PSA, PAP and TURP27 following irradiation therapy for clinically localized prostate cancer. Urology 44: 525–529

    Article  PubMed  CAS  Google Scholar 

  • Gustafsson O, Carlsson P, Norming U (1995) Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2000 men. Prostate 26: 299–309

    Article  PubMed  CAS  Google Scholar 

  • Hsieh J-T, Wu H-C, Gleave ME (1993) Autocrine regulation of prostate-specific antigen gene expression in a human pro-static cnacer ( LNCaP) subline. Cancer Res 53: 2852–2857

    PubMed  CAS  Google Scholar 

  • Israeli RS, Miller WH, Su SL (1994) Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54: 6306–6310

    PubMed  CAS  Google Scholar 

  • Iwakiri J, Gransboris K, Wehner N et al. (1993) An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence of secretion of prostate specific antigen by the periurethral glands. J Urol 149: 783–786

    PubMed  CAS  Google Scholar 

  • Jacobsen SJ, Wright GL, Lilja H et al. (1994) Comparability of the tandem-R and Imx assays for the measurement of serum prostate-specific antigen. Urology 44: 512–518

    Article  PubMed  CAS  Google Scholar 

  • Kamoshida S, Tsutsumi Y (1990) Extraprostatic localization of prostatic acid phosphatase and prostate-specific antigen: distribution of cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum Pathol 21: 1108–1111

    Article  PubMed  CAS  Google Scholar 

  • Kanety H, Madjar Y, Dagen Y et al. (1993) Serum insuline-like growth factor-binding protein-2 (IGFBR2) is increased and IGFBR3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab 77: 229–233

    Article  PubMed  CAS  Google Scholar 

  • Katz AE, de Vries GM, Begg MD et al. (1995) Enhanced reverse transcriptase-polymerase chain reaction for prostate-specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 75: 1642–1648

    Article  PubMed  CAS  Google Scholar 

  • Klee GG, Dodge LA, Zincke H et al. (1994) Measurement of serum prostate specific antigen using Imx prostate specific antigen assay. J Urol 151: 94–98

    PubMed  CAS  Google Scholar 

  • Krahn MD, Mahoney JE, Eckman MH (1994) Screening for prostate cancer. JAMA 272: 773–780

    Article  PubMed  CAS  Google Scholar 

  • Lam K-W, Li C-Y, Yam LT (1989) Improved immunohistochemical detection of prostatic acid phosphatase by a monoclonal antibody. Prostate 15: 13–21

    Article  PubMed  CAS  Google Scholar 

  • Lilja H (1985) A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 76: 1899–1903

    Article  PubMed  CAS  Google Scholar 

  • Lilja H (1993) Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to a,-antichymotrypsin. Urol Clin North Am 20: 681–686

    PubMed  CAS  Google Scholar 

  • Littrup PJ, Kane RA, Mettlin CJ et al. (1994) Cost-effective prostate cancer detection: reduction of low-yield biopsies. Cancer 74: 3146–3158

    Article  PubMed  CAS  Google Scholar 

  • Mettlin C, Murphy GP, Menck H (1994) Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the commission on cancer national cancer database, 1985–1990. Urology 43: 488–492

    Article  PubMed  CAS  Google Scholar 

  • Miller PD, Eandley I, Kirby S (1992) Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer. Br J Urol 70: 295–298

    PubMed  CAS  Google Scholar 

  • Monne M, Croce CM, Yu H et al. (1994) Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res 54: 6344–6347

    PubMed  CAS  Google Scholar 

  • Moreno JG, Croce CM, Fischer R et al. (1992) Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52: 6110–6112

    PubMed  CAS  Google Scholar 

  • Neal DE, Clejan S, Sarma D (1992) Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 20: 105–111

    Article  PubMed  Google Scholar 

  • Nishiya M, Miller GJ, Lookner DH et al. (1994) Prostate specific antigen density in patients with histologically proven prostate carcinoma. Cancer 74: 3002–3009

    Article  PubMed  CAS  Google Scholar 

  • Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907–923

    PubMed  CAS  Google Scholar 

  • Oesterling JE (1993) PSA leads the way for detecting and following prostate cancer. Contemp Urol 5: 60–81

    PubMed  CAS  Google Scholar 

  • Oesterling JE, Martin SK, Bergstrath EJ et al. (1993a) The use of prostate specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 269: 57–60

    Article  PubMed  CAS  Google Scholar 

  • Oesterling JE, Suman VJ, Zincke H et al. (1993b) PSA-detected (clinical stage Tlc or BO) prostate cancer. Pathologically significant tumors. Urol Clin North Am 20: 687–693

    Google Scholar 

  • Oesterling JE, Martin SK, Bergstrath EJ et al. (1995) The periurethral glands do not have a clinically significant effect on the serum PSA concentration. J Urol 153: 518A

    Google Scholar 

  • Partin AW, Oesterling JE (1995) The clinical usefulness of prostate specific antigen: update 1994. J Urol 152: 1358–1368

    Google Scholar 

  • Partin AW, Pound CR, Clemens JQ et al. (1993) Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 20: 713–725

    PubMed  CAS  Google Scholar 

  • Partin AW, Pearson JD, Landis PK (1994) Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology 43: 649–659

    Article  PubMed  CAS  Google Scholar 

  • Rees MA, McHugh TA, Dorr RP et al. (1995) Assessment of the utility of bone scan, CT scan and lymph node dissection in staging patients with newly diagnosed prostate cancer. J Urol 153: 352A

    Article  Google Scholar 

  • Rommel FM, Agusta VE, Breslin JA et al. (1994) The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol 151: 88–93

    PubMed  CAS  Google Scholar 

  • Schmid H-P, McNeal JE, Stamey TA (1993) Observations on the doubling time of prostate cancer. Cancer 71: 2031–2040

    Article  PubMed  CAS  Google Scholar 

  • Seaman E, Whang M, Olsson CA (1993) PSA density (PSAD). Role in patient evaluation and management. Urol Clin North Am 20: 653–663

    PubMed  CAS  Google Scholar 

  • Seiden MMV, Kantoff PW, Krithivas K (1994) Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 12: 2634–2639

    PubMed  CAS  Google Scholar 

  • Sensabaugh GF (1994) Response to Wang et al. (1994) Prostate-specific antigen, p30, γ-seminoprotein and El. Prostate 24: 109–110

    Article  CAS  Google Scholar 

  • Smith DS, Catalona WJ (1994) Rate of change in serum prostate speific antigen levels as a method of prostate cancer detection. J Urol 152: 1163–1167

    PubMed  CAS  Google Scholar 

  • Smith JA, Scaletsky R (1993) Future directions in tumor marker technology for prostate cancer. Urol Clin North Am 20: 771–777

    PubMed  Google Scholar 

  • Smith MR, Biggar S, Hussain M (1995) Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res 55: 2640–2644

    PubMed  CAS  Google Scholar 

  • Stamey TA (1995) Second Stanford conference on international standardization of prostate-specific antigen immunoassays: September 1–2, 1994. Urology 45: 173–184

    Article  PubMed  CAS  Google Scholar 

  • Stamey TA, Graves HCB, Wehner N (1993) Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J Urol 149: 787–792

    PubMed  CAS  Google Scholar 

  • Stein AVI, deKernion JB, Smith RB (1992) Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J Urol 147: 942–946

    PubMed  CAS  Google Scholar 

  • Stenman U-H, Hakama M, Knekt P et al. (1994) Serum concentrations of prostate specific antigen and its complex with a 1 -antichymotrypsin before diagnosis of prostate cancer. Lancet 344: 1594–1598

    Article  PubMed  CAS  Google Scholar 

  • Takayama TK, Krieger JN, True LD et al. (1992) Recurrent prostate cancer despite undetectable prostate specific antigen. J Urol 148: 1541–1542

    PubMed  CAS  Google Scholar 

  • Takayama TK, Vessella RL, Brawer MK et al. (1994) Urinary prostate specific antigen levels after radical prostatectomy. J Urol 151: 82–87

    PubMed  CAS  Google Scholar 

  • Tepper SL, Jagirdar J, Heath D et al. (1984) Homology between the female paraurethral ( Skene’s) glands and the prostate. Arch Pathol Lab Med 108: 423–425

    PubMed  CAS  Google Scholar 

  • Van de Voorde WM, Elgamal AA, Van Poppel HP et al. (1994) Morphologic and immunohistochemical changes in prostate cancer after preoperative hormonal therapy. Cancer 74: 3164–3175

    Article  PubMed  Google Scholar 

  • van Krieken JHJM (1993) Prostate marker immunoreactivity in salivary gland neoplasms. Am J Surg Pathol 17: 410–414

    Article  PubMed  Google Scholar 

  • Van Poppel H, De Ridder D, Elgamal AA (1995) Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. J Urol 154: 429–434

    Article  PubMed  Google Scholar 

  • Vessella RL, Lange PH (1993) Issues in the assessment of PSA immunoassays. Urol Clin North AM 20: 607–619

    PubMed  CAS  Google Scholar 

  • Walsh PC (1995) Editorial comments. J Urol 154: 304–308

    Google Scholar 

  • Wood DP, Banks ER, Humphreys S et al. (1994) Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74: 2533–2540

    Article  PubMed  Google Scholar 

  • Young CY, Montgomery BT, Andrews et al. (1991) Hormone regulation of prostatespecific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res 51: 3748–3752

    PubMed  CAS  Google Scholar 

  • Yu HE, Diamandis EP (1995) Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. J Urol 153: 1004–1008

    Article  PubMed  CAS  Google Scholar 

  • Yu HE, Diamandis EP, Levesque M et al. (1995) Expression of prostate specific antigen gene in a primary ovarian carcinoma. Clin Chem 41: S219

    Google Scholar 

  • Zhou AM, Tewari PC, Bluestein BI et al. (1993) Multiple forms of prostate specific antigen in serum: difference in immunorecognition by monoclonal and polyclonal assays. Clin Chem 39: 2483–2491

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, St. Pieter’s Hospital, Catholic University of Leuven, Brusselsestraat 69, 3000, Leuven, Belgium

    A. A. Elgamal MD (Consultant Urologist and Research Fellow), Professor H. Van Poppel MD, PhD & L. Baert MD, PhD (Professor and Chairman, Clinical Professor)

  2. Department of Radiation Oncology, University of Southern California School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    Z. Petrovich MD (Professor of Radiation Oncology and Urology, Chairman)

  3. Department of Urology and Radiation Oncology, University of Southern California School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    L. Baert MD, PhD (Professor and Chairman, Clinical Professor)

Authors
  1. A. A. Elgamal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. Petrovich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Professor H. Van Poppel MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Baert MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Southern California School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    Zbigniew Petrovich MD (Professor, Department of Radiation Oncology and Urology, Chairman, Department of Radiation Oncology) (Professor, Department of Radiation Oncology and Urology, Chairman, Department of Radiation Oncology)

  2. Department of Urology, St. Pieter’s Hospital, University of Leuven, Brusselsestraat 69, B-3000, Leuven, Belgium

    Luc Baert MD

  3. Department of Radiation Oncology and Nuclear Medicine, Medical College of Pennsylvania and Hahnemann University, 230 N. Broad Street, Philadelphia, PA, 1902-1192, USA

    Luther W. Brady MD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Elgamal, A.A., Petrovich, Z., Van Poppel, H., Baert, L. (1996). The Role of Prostate-Specific Antigen in the Management of Prostate Cancer. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Prostate. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60956-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60956-5_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64627-0

  • Online ISBN: 978-3-642-60956-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation